Free Republic 2nd Qtr 2025 Fundraising Target: $81,000 Receipts & Pledges to-date: $82,072
101%
Woo hoo!! OVER THE TOP!! Congratulations everyone!! God bless.

Keyword: panitumumab

Brevity: Headers | « Text »
  • Amgen Eyes Wider Market Reach With Osteoporosis Drug

    03/11/2006 8:04:28 PM PST · by BenLurkin · 3 replies · 382+ views
    Investor's Business Daily ^ | Friday March 10, 7:00 pm ET | Gloria Lau
    An estimated 10 million Americans suffer from osteoporosis, according to the National Institutes of Health. Another 34 million are considered at increased risk for getting the bone disease. A good many of those patients stand to benefit if a new osteoporosis drug from Amgen (NasdaqNM:AMGN - News) turns out to be successful. Phase two data on the investigational drug, dubbed Denosumab, was recently published in the New England Journal of Medicine. The drug was given in twice-yearly injections. A total of 412 postmenopausal women with low bone marrow density were randomly assigned to receive Denosumab, Merck's (NYSE:MRK - News) Fosamax...